Source: GlobeNewswire

Press Release: KVK-TECH : KemPharm Enters Into License Agreement with KVK Tech for the Commercialization of APADAZ®

Partnership with KVK, One of the Largest Manufacturers of Controlled Substances in the U.S., Opens the Door for Commercial Launch of APADAZ with PBMs and MCOs

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Anthony Tabasso's photo - President & CEO of KVK-TECH

President & CEO

Anthony Tabasso

CEO Approval Rating

- -/100

Read more